Effect of thoracic epidural anaesthesia on serum vascular endothelial growth factor C and cytokines in patients undergoing anaesthesia and surgery for colon cancer

British Journal of Anaesthesia

Volumn 113, Issue SUPPL. 1, 2014, Pages

  Xu, Y J ^a,b   Chen, W K ^a,b   Zhu, Y ^a,b   Wang, S L ^a,b   Miao, C H ^a,b  

^a FUDAN UNIVERSITY SHANGHAI CANCER CENTER   (China)

^b FUDAN UNIVERSITY   (China)

Author keywords

anaesthesia general; anaesthetic techniques epidural; cancer colorectal; surgery colorectal

Indexed keywords

CISATRACURIUM; INTERLEUKIN 10; INTERLEUKIN 6; MIDAZOLAM; PROPOFOL; ROPIVACAINE; SUFENTANIL; TRANSFORMING GROWTH FACTOR BETA; VASCULOTROPIN C;

ADULT; AGED; ARTICLE; CANCER PATIENT; CANCER RECURRENCE; CANCER SURGERY; CLINICAL ARTICLE; COLON CANCER; COMPARATIVE STUDY; CONTROLLED STUDY; COUGHING; FEMALE; GENERAL ANESTHESIA; HUMAN; LOADING DRUG DOSE; MALE; METASTASIS; PATIENT CONTROLLED ANALGESIA; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL; TARGET CONTROLLED INFUSION PUMP; THORAX EPIDURAL ANESTHESIA; VERY ELDERLY; VISUAL ANALOG SCALE;

ANAESTHESIA, GENERAL; ANAESTHETIC TECHNIQUES, EPIDURAL; CANCER, COLORECTAL; SURGERY, COLORECTAL;

ADULT; AGED; AGED, 80 AND OVER; ANESTHESIA, EPIDURAL; ANESTHESIA, GENERAL; ANESTHETICS, INTRAVENOUS; ANGIOGENESIS INDUCING AGENTS; COLONIC NEOPLASMS; CYTOKINES; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASM PROTEINS; NEOPLASM STAGING; PAIN MEASUREMENT; PAIN, POSTOPERATIVE; POSTOPERATIVE PERIOD; PROPOFOL; PROSPECTIVE STUDIES; THORACIC VERTEBRAE; VASCULAR ENDOTHELIAL GROWTH FACTOR C; YOUNG ADULT;

EID: 84904980684     PISSN: 00070912     EISSN: 14716771     Source Type: Journal    
DOI: 10.1093/bja/aeu148     Document Type: Article

References (43)

1. Siegel R, Naishadham D, Jemal A. Cancer statistics, 2012. CACancer J Clin 2012; 1: 10-29
2. Harris GJ, Church JM, Senagore AJ, et al. Factors affecting local recurrence of colonic adenocarcinoma. Dis Colon Rectum 2002; 45: 1029-34
3. Snyder GL, Greenberg S. Effect of anaesthetic technique and other perioperative factorson cancer recurrence. Br J Anaesth 2010; 105: 106-15
4. Colvin LA, Fallon MT, Buggy DJ. Cancer biology, analgesics, and anaesthetics: is there a link? Br J Anaesth 2012; 109: 140-3
5. Folkman J. What is the evidence that tumors are angiogenesis dependent? J Natl Cancer Inst 1990; 82: 4-6
6. Iinuma H, Watanabe T, Mimori K, et al. Clinical significance of circulating tumor cells, including cancer stem-like cells, in peripheral blood for recurrence and prognosis in patients with Dukes' stage B and C colorectal cancer. J Clin Oncol 2011; 29: 1547-55
7. Kwon KA, Kim SH, Oh SY, et al. Clinical significance of preoperative serum vascular endothelial growth factor, interleukin-6, and C-reactive proteinl evelin colorectal cancer. BMC Cancer 2010;10: 203
8. Ahlers O, Nachtigall I, Lenze J, et al. Intraoperative thoracic epidural anaesthesia attenuates stress-induced immunosuppression in patients undergoing major abdominal surgery. Br J Anaesth 2008; 101: 781-7
9. Christopherson R, James KE, Tableman M, Marshall P, Johnson FE. Long-term survival after colon cancer surgery: a variation associated with choice of anesthesia. Anesth Analg 2008; 107: 325-32
10. Gottschalk A, Ford JG, Regelin CC, et al. Association between epi-dural analgesia and cancer recurrence after colorectal cancer surgery. Anesthesiology 2010; 113: 27-34
11. Gupta A, Bjornsson A, Fredriksson M, Hallbook O, Eintrei C. Reduction in mortality after epidural anaesthesia and analgesia in patients undergoing rectal but not colonic cancer surgery: a retrospective analysis of data from 655 patients in central Sweden. Br J Anaesth 2011; 107: 164-70
12. Cummings KC, Xu F, Cummings LC, Cooper GS. Acomparisonofepi-dural analgesia and traditional pain management effects on survival and cancer recurrence after colectomy. Anesthesiology 2012; 116: 797-806
13. Heaney A, Buggy DJ. Can anaesthetic and analgesic techniques affect cancer recurrence or metastasis? Br J Anaesth 2012; 109: i17-28
14. Inada T, Kubo K, Shingu K. Possible link between cyclooxygenase- inhibiting and antitumor properties of propofol. J Anesth 2011; 25: 569-75
15. Looney M, Doran P, Buggy DJ. Effect of anesthetic technique on serum vascular endothelial growth factor C and transforming growth factor b in women undergoing anesthesia and surgery for breast cancer. Anesthesiology 2010; 113: 1118-25
16. Shaheen RM, Davies DW, Liu W. Antiangiogenic therapy targeting the tyrosine kinase receptor for VEGF receptor inhibits the growth of colon cancer liver metastasis and induces tumorand endothelial cell apoptosis. Cancer Res 1999; 59: 5412-6
17. 2. Anesth Analg 2005; 100: 244-9
18. Tavare AN, Perry NJ, Benzonana LL, Takata M, Ma D. Cancer recurrence after surgery: direct and indirect effects of anesthetic agents. Int J Cancer 2012; 130: 1237-50
19. Melamed R, Bar-Yosef S, Shakhar G, Shakhar K, Ben-Eliyahu S. Suppression of natural killer cell activity and promotion of tumor metastasisbyketamine, thiopental, and halothane, but not bypro-pofol: mediating mechanisms and prophylactic measures. Anesth Analg 2003; 97: 1331-9
20. Neeman N, Ben-Eliyahu S. Surgery and stress promote cancer metastasis: new outlooks on perioperative mediating mechanisms and immune involvement. Brain Behav Immun 2013; 30: S32-40
21. Kozian A, Schilling T, Hachenberg T. Non-analgetic effects of thoracic epidural anaesthesia. Curr Opin Anaesthesiol 2005; 18: 29-34
22. Zhang Y, Meng X, Zeng HS, et al. Serumvascularendothelial growth factor-Clevels: apossible diagnosticmarker for lymphnode metas-tasisin patients with primary non-small cell lung cancer. Oncol Lett 2013; 6: 545-9
23. Miyazaki T, Okada N, Ishibashi K, et al. Clinical significance of plasma level of vascular endothelial growth factor-C in patients with colorectal cancer. Jpn J Clin Oncol 2008; 38: 839-43
24. Bachman KE, Park BH. Duel nature of TGF-beta signaling: tumor suppressor vs. tumor promoter. Curr Opin Oncol 2005; 17: 49-54
25. Xiong B, Yuan HY, Hu MB, et al. Transforming growth factor-beta1 in invasion and metastasis in colorectal cancer. World JGastroenterol 2002; 8: 674-8
26. Sun G, Cao D, Sun Z, Zhou K, Wang Y, Liu H. TGF-bpromotes colorec-tal cancer cell growth in vitro and in vivo. Hepatogastroenterology 2013; 60: 715-9
27. Coussens LM, Werb Z. Inflammation and cancer. Nature 2002; 420: 860-7
28. deVisser KE, Eichten A, Coussens LM. Paradoxical roles of the immune system during cancer development. Nature 2006; 6: 24-37
29. Hussain SP, Harris CC. Inflammation and cancer: an ancient link with novel potentials. Int J Cancer 2007; 121: 2373-80
30. Cohen T, Nahari D, Cerem LW, Neufeld G, Levi BZ. Interleukin 6 induces the expression of vascular endothelial growth factor. J Biol Chem 1996; 271: 736-41
31. Shibata Y, Foster LA, Kurimoto M, et al. Immunoregulatory roles of IL-10 in innate immunity: IL-10 inhibits macrophage production of IFN-gamma-inducing factors but enhances NK cell production of IFN-gamma. J Immunol 1998; 161: 4283-8
32. Asadullah K, Sterry W, Volk HD. Interleukin-10 therapy-reviewof a new approach. Pharmacol Rev 2003; 55: 241-69
33. Deegan CA, Murray D, Doran P, et al. Anesthetic technique and the cytokine and matrix metalloproteinase response to primary breast cancer surgery. Reg Anesth Pain Med 2010; 35: 490-5
34. Votta-Velis EG, Piegeler T, Minshall RD, et al. Regional anaesthesia and cancer metastases: the implication of local anaesthetics. Acta Anaesthesiol Scand 2013; 57: 1211-29
35. Werdehausen R, Braun S, Fazeli S, et al. Lipophilicity but not stereo-specificity is a major determinant of local anaesthetic induced cytotoxicity in human T-lymphoma cells. Eur J Anaesthesiol 2012; 29: 35-41
36. Piegeler T, Votta-Velis EG, Liu G, et al. Antimetastatic potential of amide-linked local anesthetics: inhibition of lung adenocarcinoma cell migration and inflammatory Src signaling independent of sodium channel blockade. Anesthesiology 2012; 117: 548-59
37. Lucchinetti E, Awad AE, Rahman M, et al. Antiproliferative effects of local anesthetics on mesenchymal stem cells: potential implications for tumor spreading and wound healing. Anesthesiology 2012; 116: 841-56
38. Maruo Y, Gochi A, Kaihara A, et al. ICAM-1 expression and the soluble ICAM-1 level for evaluating the metastatic potential of gastric cancer. Int J Cancer 2002; 100: 486-90
39. Crane CA, Han SJ, Barry JJ, Ahn BJ, Lanier LL, Parsa AT. TGF-beta downregulates the activating receptor NKG2D on NK cells and CD8+ Tcells in glioma patients. Neuro Oncol 2010; 12: 7-13
40. Baxevanis CN, Papilas K, Dedoussis GV, Pavlis T, Papamichail M. Abnormal cytokine serum levels correlate with impaired cellular immune responses after surgery. Clin Immunol Immunopathol 1994; 71: 82-8
41. Gottschalk A, Sharma S, Ford J, Durieux ME, Tiouririne M. Review article: the role of the perioperative period in recurrence after cancer surgery. Anesth Analg 2010; 110: 1636-43
42. Kavanagh T, Buggy DJ. Can anaesthetic technique effect postoperative outcome? Curr Opin Anesthesiol 2012; 25: 185-98
43. Niwa H, Rowbotham DJ, Lambert DG, Buggy DJ. Can anesthetic techniques or drugs affect cancer recurrence in patients undergoing cancer surgery? J Anesth 2013; 27: 731-41